Targeting, controlling and treating a wide range of bacterial infections, Trobix Bio leverages its ActiSense™ and GOTraP™ platform technologies to springboard products across multiple business sectors.
The only available technology capable of creating a selection pressure to reverse antibiotic resistance and thus, establishes a sustained antibiotic sensitive environment.
Trobix Bio plans to develop products that will be unique in their capability to enable treating patients infected with antibiotic resistant bacteria, reducing by far the risk of transmission of resistant bacteria.
In vivo selection of antibiotic sensitive bacteria that enables treatment using standard antibiotics.
Innovative DNA delivery technology that targets a wide range of bacterial pathogens.
Highly selective products that do not disrupt the natural microbiome.
Circumvent bacteria from developing anti-microbial resistance to our products.
Reduction in the horizontal transfer of antibiotic resistance.
Ease of scale up that produces safe non-GMO products.